FULC
Price
$9.65
Change
+$0.96 (+11.05%)
Updated
Oct 15, 04:59 PM (EDT)
Capitalization
470.06M
28 days until earnings call
Intraday Buy/Sell Signals
NUVB
Price
$3.78
Change
+$0.23 (+6.48%)
Updated
Oct 15, 04:59 PM (EDT)
Capitalization
1.22B
21 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

FULC vs NUVB

Header iconFULC vs NUVB Comparison
Open Charts FULC vs NUVBBanner chart's image
Fulcrum Therapeutics
Price$9.65
Change+$0.96 (+11.05%)
Volume$19.94K
Capitalization470.06M
Nuvation Bio
Price$3.78
Change+$0.23 (+6.48%)
Volume$71.69K
Capitalization1.22B
FULC vs NUVB Comparison Chart in %
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. NUVB commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and NUVB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (FULC: $8.69 vs. NUVB: $3.55)
Brand notoriety: FULC and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 111% vs. NUVB: 83%
Market capitalization -- FULC: $470.06M vs. NUVB: $1.22B
FULC [@Biotechnology] is valued at $470.06M. NUVB’s [@Biotechnology] market capitalization is $1.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, both FULC and NUVB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 5 TA indicator(s) are bullish while NUVB’s TA Score has 2 bullish TA indicator(s).

  • FULC’s TA Score: 5 bullish, 5 bearish.
  • NUVB’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, FULC is a better buy in the short-term than NUVB.

Price Growth

FULC (@Biotechnology) experienced а -5.95% price change this week, while NUVB (@Biotechnology) price change was -3.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +18.38%, and the average quarterly price growth was +83.19%.

Reported Earning Dates

FULC is expected to report earnings on Nov 12, 2025.

NUVB is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($1.22B) has a higher market cap than FULC($470M). FULC YTD gains are higher at: 84.894 vs. NUVB (33.459). FULC has higher annual earnings (EBITDA): -81.28M vs. NUVB (-201.17M). NUVB has more cash in the bank: 608M vs. FULC (214M). FULC has less debt than NUVB: FULC (7.57M) vs NUVB (57.8M). NUVB has higher revenues than FULC: NUVB (14.4M) vs FULC (0).
FULCNUVBFULC / NUVB
Capitalization470M1.22B39%
EBITDA-81.28M-201.17M40%
Gain YTD84.89433.459254%
P/E RatioN/AN/A-
Revenue014.4M-
Total Cash214M608M35%
Total Debt7.57M57.8M13%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCNUVB
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
87%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DGAGX41.12N/A
N/A
BNY Mellon Appreciation Investor
SDVSX17.72N/A
N/A
Sit Dividend Growth S
PEIOX42.06N/A
N/A
Principal Equity Income R3
IMOWX26.44N/A
N/A
Voya MidCap Opportunities W
LEQIX13.16N/A
N/A
LoCorr Dynamic Opportunity I